Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Leber congenital amaurosis (LCA), an inherited retinal degeneration, causes severe visual dysfunction in children and adolescents. In patients with LCA, pathogenic variants, such as RPE65 , are evident in specific genes, related to the functions of retinal pigment epithelium and photoreceptors. In contrast to the original Cas9, base editing tools can correct pathogenic substitutions without generation of DNA double-stranded breaks (DSBs). In this study, dual adeno-associated virus (AAV) vectors containing split adenine base editors (ABEs) with trans -splicing intein were prepared for in vivo base editing in retinal degeneration of 12 ( rd12 ) mice, an animal model of LCA, possessing a nonsense mutation of C to T transition in the Rpe65 gene (p.R44X). Subretinal injection of AAV-ABE in retinal pigment epithelial cells of rd12 mice resulted in an A to G transition. The on-target editing was sufficient for recovery of wild-type mRNA, RPE65 protein, and light-induced electrical responses from the retina. Compared with our previous therapeutic editing strategies using Cas9 and prime editing, or with the gene transfer strategy shown in the current study, our results suggest that, considering the editing efficacy and functional recovery, ABEs could be a strong, reliable method for correction of pathogenic variants in the treatment of LCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Bae, S., Park, J., & Kim, J.-S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu048 · Cited by 2,339
Self-citationRussell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952
Kosicki, M., Tomberg, K., & Bradley, A. (2018) · Nature Biotechnology · doi:10.1038/nbt.4192 · Cited by 1,883
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Engineered CRISPR-Cas9 nuclease with expanded targeting space
Nishimasu, H., Shi, X., Ishiguro, S., Gao, L., Hirano, S., Okazaki, S., Noda, T., Abudayyeh, O. O., Gootenberg, J. S., Mori, H., et al. (2018) · Science · doi:10.1126/science.aas9129 · Cited by 1,100
Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0453-z · Cited by 1,020
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
Koblan, L. W., Doman, J. L., Wilson, C., Levy, J. M., Tay, T., Newby, G. A., Maianti, J. P., Raguram, A., & Liu, D. R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4172 · Cited by 944
Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle
Redmond., T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J.-X., Crouch, R. K., & Pfeifer, K. (1998) · Nature Genetics · doi:10.1038/3813 · Cited by 929
CIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets
Tsai, S. Q., Nguyen, N. T., Malagon-Lopez, J., Topkar, V. V., Aryee, M. J., & Joung, J. K. (2017) · Nature Methods · doi:10.1038/nmeth.4278 · Cited by 814
Research works printed but not linked: 31
- Sahel, 2011, Spotlight on childhood blindness, J. Clin. Invest., 121, 2145, 10.1172/JCI58300 · DOI
- Cideciyan, 2019, Leber congenital amaurosis (LCA): potential for improvement of vision, Invest. Ophthalmol. Vis. Sci., 60, 1680, 10.1167/iovs.19-26672 · DOI
- Jo, 2019, CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis, Sci. Adv., 5, eaax1210, 10.1126/sciadv.aax1210 · DOI · Paper page
- Jang, 2020, Current trends in gene recovery mediated by the CRISPR-Cas system, Exp. Mol. Med., 52, 1016, 10.1038/s12276-020-0466-1 · DOI
- Habib, 2022, Comprehensive analysis of prime editing outcomes in human embryonic stem cells, Nucleic Acids Res., 50, 1187, 10.1093/nar/gkab1295 · DOI · Paper page
- Astuti, 2016, Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark, Eur. J. Hum. Genet., 24, 1071, 10.1038/ejhg.2015.241 · DOI
- Suh, 2021, Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing, Nat. Biomed. Eng., 5, 169, 10.1038/s41551-020-00632-6 · DOI · Paper page
- Pang, 2005, Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA), Mol. Vis., 11, 152
- Jespersgaard, 2019, Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy, Sci. Rep., 9, 1219, 10.1038/s41598-018-38007-2 · DOI
- Zhong, 2019, Seven novel variants expand the spectrum of RPE65-related Leber congenital amaurosis in the Chinese population, Mol. Vis., 25, 204
- Jeong, 2019, Construction of non-canonical PAM-targeting adenosine base editors by restriction enzyme-free DNA cloning using CRISPR-Cas9, Sci. Rep., 9, 4939, 10.1038/s41598-019-41356-1 · DOI · Paper page
- Jeong, 2020, Current status and challenges of DNA base editing tools, Mol. Ther., 28, 1938, 10.1016/j.ymthe.2020.07.021 · DOI
- Osborn, 2020, Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs, J. Invest. Dermatol., 140, 338, 10.1016/j.jid.2019.07.701 · DOI
- Levy, 2020, Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses, Nat. Biomed. Eng., 4, 97, 10.1038/s41551-019-0501-5 · DOI · Paper page
- Stevens, 2017, A promiscuous split intein with expanded protein engineering applications, Proc. Natl. Acad. Sci. USA, 114, 8538, 10.1073/pnas.1701083114 · DOI · Paper page
- Villiger, 2018, Treatment of a metabolic liver disease by in vivo genome base editing in adult mice, Nat. Med., 24, 1519, 10.1038/s41591-018-0209-1 · DOI · Paper page
- Yang, 2020, Amelioration of an inherited metabolic liver disease through creation of a de novo start codon by cytidine base editing, Mol. Ther., 28, 1673, 10.1016/j.ymthe.2020.05.001 · DOI
- Esumi, 2009, BEST1 expression in the retinal pigment epithelium is modulated by OTX family members, Hum. Mol. Genet., 18, 128, 10.1093/hmg/ddn323 · DOI · Paper page
- Rees, 2019, Analysis and minimization of cellular RNA editing by DNA adenine base editors, Sci. Adv., 5, eaax5717, 10.1126/sciadv.aax5717 · DOI · Paper page
- Zhou, 2019, Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis, Nature, 571, 275, 10.1038/s41586-019-1314-0 · DOI · Paper page
- Kim, 2006, Structural and kinetic characterization of Escherichia coli TadA, the wobble-specific tRNA deaminase, Biochemistry, 45, 6407, 10.1021/bi0522394 · DOI · Paper page
- Lee, 2019, CRISPR-pass: gene rescue of nonsense mutations using adenine base, Mol. Ther., 27, 1364, 10.1016/j.ymthe.2019.05.013 · DOI · Paper page
- Jo, 2022, In vivo application of base and prime editing to treat inherited retinal diseases, Prog. Retin. Eye Res., 101132, 101132
- Jang, 2022, Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases, Nat. Biomed. Eng., 6, 181, 10.1038/s41551-021-00788-9 · DOI · Paper page
- Jeong, 2021, Adenine base editor engineering reduces editing of bystander cytosines, Nat. Biotechnol., 39, 1426, 10.1038/s41587-021-00943-2 · DOI · Paper page
- Gaudelli, 2020, Directed evolution of adenine base editors with increased activity and therapeutic application, Nat. Biotechnol., 38, 892, 10.1038/s41587-020-0491-6 · DOI · Paper page
- Park, 2015, Limbal approach-subretinal injection of viral vectors for gene therapy in mice retinal pigment epithelium, J. Vis. Exp., e53030
- Bae, 2014, Microhomology-based choice of Cas9 nuclease target sites, Nat. Methods, 11, 705, 10.1038/nmeth.3015 · DOI · Paper page
- Douglas, 2005, Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system, Vis. Neurosci., 22, 677, 10.1017/S0952523805225166 · DOI · Paper page
- Prusky, 2004, Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system, Invest. Ophthalmol. Vis. Sci., 45, 4611, 10.1167/iovs.04-0541 · DOI · Paper page
- Kim, 2008, Absence of intravitreal bevacizumab-induced neuronal toxicity in the retina, Neurotoxicology, 29, 1131, 10.1016/j.neuro.2008.06.006 · DOI
Cited by
Engineered Virus-like Particles for Efficient in Vivo Delivery of Therapeutic Proteins
Banskota, S., Raguram, A., Suh, S., Du, S. W., Davis, J. R., Choi, E. H., Wang, X., Nielsen, S. C., Newby, G. A., Randolph, P. B., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.021 · Cited by 668
Therapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 522
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Ail, D., Malki, H., Zin, E. A., & Dalkara, D. (2023) · The Application of Clinical Genetics · doi:10.2147/tacg.s383453 · Cited by 40
Carvalho, C., Lemos, L., Antas, P., & Seabra, M. C. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1270561 · Cited by 21
Innovative therapies for inherited retinal dystrophies: navigating DNA, RNA, and protein approaches
Gómez-Escribano, A. P., García-García, G., Pérez-Santamarina, E., Aller-Mañas, E., Vázquez-Manrique, R. P., & Millán-Salvador, J. M. (2025) · eBioMedicine · doi:10.1016/j.ebiom.2025.105751 · Cited by 6
“56 In non-dividing cells, CRISPR/Cas9 induces double-strand breaks that can lead to insertions and deletions (indels) 57 by non-homologous end-joining repair.”
Metadata
- Authors
- Jo, D. H., Jang, H.-K., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 31
- Pages
- 16-27
- ISSN
- 2162-2531 (ISSN-L)
- OpenAlex
- W4313201182
- Cited by
- 59
- References
- 23
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Research Foundation of Korea (2018M3D1A1058826, 2020M3A9I4036074, 2021M3A9H3015389, 2021R1A2C3012908, 2022M3A9E4017127)
- Seoul National University
- Korea Drug Development Fund
- Ministry of Trade, Industry and Energy
- Seoul National University Hospital (0320213010)
- Ministry of Science, ICT and Future Planning
- Ministry of Health and Welfare (HN21C0917)
- Korea Research Institute of Bioscience and Biotechnology (KGM5362111)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing. https://app.cochat.ai/papers/10.1016/j.omtn.2022.11.021
- The paper
- Jo, D. H., Jang, H.-K., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2023). Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing. Molecular Therapy - Nucleic Acids. https://doi.org/10.1016/j.omtn.2022.11.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.